发明名称 HETEROARYL COMPOUNDS USEFUL AS INHIBITORS OF GSK-3
摘要 The present invention relates to compounds of formula I wherein: Ring A is an optionally substituted 5-7 membered, partially unsaturated or fully unsaturated ring having 0-3 heteroatoms independently selected from nitrogen, oxygen or sulfur, and wherein Ring A is optionally fused to an optionally substituted saturated, partially unsaturated or fully unsaturated 5-8 member ring having 0-3 heteroatoms independently selected from nitrogen, oxygen or sulfur; Ring B is an optionally substituted 5-6 membered ring having 0 to 4 heteroatoms, independently selected from nitrogen, oxygen, or sulfur, wherein said ring has a first substituent, -N(R<1>)2, in the position adjacent to the point of attachment, and is optionally substituted by up to two additional substituents. Compoounds of formula I are useful as inhibitors of GSK-3 and Lck protein kinases. The present invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention and methods of utilizing those compositions in the treatment and prevention of various disorders, such as diabetes, Alzheimer's disease, and transplant rejection.
申请公布号 WO03066629(A3) 申请公布日期 2003.10.30
申请号 WO2003US03655 申请日期 2003.02.06
申请人 VERTEX PHARMACEUTICALS INCORPORATED;HARBESON, SCOTT L.;ARNOST, MICHAEL, J.;GREEN, JEREMY;SAVIC, VLADIMIR 发明人 HARBESON, SCOTT L.;ARNOST, MICHAEL, J.;GREEN, JEREMY;SAVIC, VLADIMIR
分类号 C07D235/18;A61K31/4184;A61K31/4245;A61K31/437;A61K31/4427;A61K31/4439;A61K31/501;A61K31/506;A61K31/519;A61K31/52;A61K31/5377;A61P3/10;A61P9/00;A61P9/10;A61P11/06;A61P17/14;A61P25/00;A61P25/14;A61P25/16;A61P25/18;A61P25/28;A61P37/08;C07D401/04;C07D403/04;C07D409/04;C07D413/04;C07D413/14;C07D471/04;C07D487/04 主分类号 C07D235/18
代理机构 代理人
主权项
地址